GLP-1 R

This peptide targets the glucagon‑like peptide‑1 receptor, a key node in incretin signaling, insulin sensitivity, and appetite regulation. Researchers use it to study postprandial glucose control, gastric emptying, and satiety — often in models of metabolic syndrome or energy imbalance. It’s frequently paired with amylin analogs like Cagrilintide, and increasingly referenced in triple agonist frameworks that combine GLP‑1, GIP, and glucagon receptor activity for multi‑axis modulation.

• ≥99% purity
• Batch-specific COA available
• U.S.-based fulfillmen